drugset / Trial / NCT02547597

Comparison of Carvedilol and Atenolol on Anti-anginal and Metabolic Effects in Patients With Stable Angina Pectoris

NCT02547597

Phase 4 Completed 99 enrolled Gachon University Gil Medical Center
RandomizedParallel-groupOpen-labelTreatment

Summary

There are few data regarding anti-anginal effects between beta-blockers with and without vasodilating property. Beta-blocker without vasodilating property is generally known to have unfavorable effects on glucose and lipid metabolism. Therefore, the investigators compared carvedilol and atenolol on anti-anginal and metabolic effects in patient with stable angina pectoris.

Timeline

Start
2011-04
Primary completion
2013-08
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atenolol Other / unclassified 50 mg
Subject Carvedilol Other / unclassified 25 mg

Indications

No indication recorded.